NaturalShrimp Price, Forecast, Insider, Ratings, Fundamentals & Signals

The company increases production to support market expansion dallas , may 1, 2024 /prnewswire/ -- natural shrimp, incorporated. (otcqb: shmp) (the "company" or "nsi"), a biotechnology aquaculture company that has developed and patented the first seafood-focused commercially operational ras (recirculating aquaculture system), today announced that, as a result of significantly increased production at its webster city facility, the company is in the process of identifying, contacting and securing new commercial outlets for the sale of the company's sushi grade shrimp.

Patented electrocoagulation (ec) and hydrogas™ technologies results from trial at aquaculture farm in japan dallas, april 18, 2024 /prnewswire/ -- natural shrimp, inc. (otcqb: shmp) (the "company" or "nsi"), a biotechnology aquaculture company that has developed and patented the first seafood-focused commercially operational ras (recirculating aquaculture system), today announced it has completed at the end of february 2024 a successful 6-month trial in japan with the company's patented electrocoagulation (ec) and hydrogas™ technologies (the "equipment"). one week after arriving in japan, the natural shrimp and hydrenesis' team, with the assistance of the japanese team, installed and began operating the equipment at the japanese shrimp research facility.

Company also extending engagement with investment banking partner to underwrite capital raise dallas , april 17, 2024 /prnewswire/ -- natural shrimp incorporated (otcqb: shmp), a biotechnology aquaculture company (the "company") that has developed and patented the first seafood-focused commercially operational ras (recirculating aquaculture system), is pleased to announce that the company has filed an initial application to list its securities on the chicago board of options exchange (cboe us) bzx exchange (the "exchange"). in addition, the company has extended its engagement with its investment banking partner to underwrite a capital raise concurrent with the cboe us listing.

Japan, thailand, australia and europe dallas , feb. 15, 2024 /prnewswire/ -- naturalshrimp incorporated (otcqb: shmp), a biotechnology aquaculture company that has developed and patented the first shrimp-focused commercially operational ras (recirculating aquaculture system), is pleased to announce the successful filing of patents in japan, thailand, and australia. these filings mark a significant step in our commitment to advancing sustainable aquaculture practices and ensuring the future of global seafood production.

Phoenix, az / accesswire / september 12, 2023 / the stock day podcast welcomed naturalshrimp (otcqb:shmp)("the company"), a publicly traded biotechnology aquaculture company, headquartered in dallas, with production facilities located near san antonio, texas, and webster city, iowa. gerald easterling, ceo of naturalshrimp, joined stock day host, everett jolly.

Company to Showcase Gourmet-Grade Pacific White Shrimp to LD Micro Invitational XII Attendees

US stock futures traded higher this morning on Friday. Investors, meanwhile, focused on some notable insider trades.

Company to Showcase Gourmet-Grade Pacific White Shrimp to Conference Attendees During Welcome Reception at Luxe Sunset Boulevard Hotel

DALLAS, TX, Sept. 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused, commercially operational RAS (Recirculating Aquaculture System), today announced initial trial results of its short-term validation study at the Marineholmen RASLab, in Bergen Norway, to evaluate the effects of hyper-antioxidant technologies on oxidation and fish health in Recirculating Aquaculture Systems (RAS).

DALLAS, TX, Sept. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused, commercially operational RAS (Recirculating Aquaculture System), announced the debut of its new investor relations website .

DALLAS, TX, Aug. 26, 2021 (GLOBE NEWSWIRE) -- via  NewMediaWire --  NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused, commercially operational RAS (Recirculating Aquaculture System), today closed the previously announced acquisition of the aquaculture assets of Hydrenesis Aquaculture, LLC for $12,500,000, consisting of $4,000,000 in cash and the balance due in NSI common stock, including a stock consideration payment at a price of $0.505 per share.

DALLAS, TX, July 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture System), today announced the appointment of Marco Van Den Berg to lead the Company's sales and marketing activities, with responsibility for business in North America. Marco will initially act in a consulting capacity before transitioning to the position of Vice President of Sales.

Patent Application Incorporates New Novel Improvements to Recirculating Aquaculture System and Treatment Method for Aquatic Species

New Office Expansion Enables NaturalShrimp to Accelerate Growth in Sales & Marketing with State-of-the-Art Test Kitchen & Dining Area

Dallas, Texas, June 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused commercially operational RAS (Recirculating Aquaculture System), announced today that it has closed a registered direct offering of 7,500,000 shares of the Company's common stock for gross proceeds of $3,000,000 pursuant to an effective shelf registration statement on Form S-3. The investor purchased the shares at a fixed price of $0.40 per share. This brings the total raised under the S-3 to $18M at an average price of $.525/share.